NCT06522828
A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients
StatusUnknown
PhasePhase 2
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Aug 2024 to Oct 10, 2024
- Study site revised
- Minor Study title shortened, about 2 wordsv2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
ORR
Timeframe: 12 months
Safety and tolerability
Timeframe: 12 months
Secondary (1)
PFS
Arms and interventions
SSGJ-707(dose 1)+ carboplatin + paclitaxelExperimental
SSGJ-707(dose 2)+ carboplatin + paclitaxelExperimental
SSGJ-707(dose 3)+ carboplatin + paclitaxelExperimental
SSGJ-707(dose 4)+ paclitaxelExperimental
Drugs: SSGJ-707, carboplatin, paclitaxel
Sites
1 site in 1 country
- Chongqing Cancer HospitalChongqing, China